Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...

On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, ...

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...

Vivos Therapeutics shares rose on Wednesday after the company said its oral medical device for pediatric sleep apnea and snoring received 510(k) clearance from the Food and Drug Administration. Shares ...

(RTTNews) - Vivos Therapeutics, Inc. (VVOS) announced on Wednesday that it has obtained 510(k) clearance from the FDA for its DNA oral medical device aimed at treating moderate to severe obstructive ...

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

Vivos Therapeutics (NASDAQ: VVOS) , a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

Charting, Price Performance, News & Related Contracts.

This study examined the effect of Vivos' DNA oral medical device on increasing the pharyngeal airway ... arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and ...

Sleep apnea occurs when there is a repeated air blockage in the upper airway or a pause in breathing during sleep. Insomnia ...

Oral, or dental, appliances are another treatment option for older children with sleep apnea. Two types of devices known as mandibular repositioning mouthpieces and tongue stabilizing devices worn ...

It’s the age of personal health technology—from apps to wearable devices ... Academy of Dental Sleep Medicine, adds, “The ...